Demystifying serotonin syndrome (or serotonin toxicity).

Area of Science:

• Pharmacology
• Clinical Toxicology
• Neuroscience

Background:

• Serotonin toxicity arises from excessive serotonin in brain synapses.
• While severe cases requiring hospitalization are rare, patients exhibit neuromuscular, autonomic, and mental status changes.
• Mild cases are generally not fatal.

Purpose of the Study:

• To review symptoms and causative drugs of serotonin toxicity (serotonin syndrome).
• To examine the mechanisms of action for drugs causing serotonin toxicity.
• To provide primary care providers with strategies for prevention and identification.

Main Methods:

• Searched PubMed and Google Scholar for articles on serotonin toxicity, causes, and differential diagnosis.
• Utilized search terms including "serotonin syndrome," drug classes, and diagnostic terms.
• Consulted experts in psychiatric medicine, pharmacy, pharmacology, and toxicology.

Main Results:

• Serotonin toxicity is drug-induced, resulting from elevated synaptic serotonin.
• Commonly implicated drugs include monoamine oxidase inhibitors, serotonin reuptake inhibitors, and serotonin releasers.
• Combinations of drugs, particularly MAOIs with SSRIs or SNRIs, pose the highest risk.

Conclusions:

• Family physicians are crucial in identifying and preventing serotonin syndrome.
• Patient education on recognizing symptoms and ongoing monitoring are key strategies.
• Early identification and intervention by primary care providers can improve patient outcomes.